US Stock MarketDetailed Quotes
CTCX Carmell
- 0.285
- +0.059+26.20%
Close Dec 24 13:00 ET
- 0.260
- -0.025-8.64%
Post 16:59 ET
5.95MMarket Cap-0.95P/E (TTM)
0.480High0.261Low61.35MVolume0.433Open0.226Pre Close23.68MTurnover470.85%Turnover RatioLossP/E (Static)20.91MShares4.00052wk High-1.47P/B3.71MFloat Cap0.20052wk Low--Dividend TTM13.03MShs Float13.310Historical High--Div YieldTTM96.90%Amplitude0.200Historical Low0.386Avg Price1Lot Size
About Carmell Company
Carmell Corp. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. Its products include Bone Healing Accelerant and Tissue Healing Accelerant. The company was founded on November 5, 2008 and is headquartered in Pittsburgh, PA.
Company Profile
SymbolCTCX
Company NameCarmell
Listing DateSep 23, 2021
Founded2008
CEOMs. Kendra Bracken-Ferguson
MarketNASDAQ
Employees10
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address2403 Sidney Street,Suite 300
CityPittsburgh
ProvincePennsylvania
CountryUnited States of America
Zip Code15203
Phone1-412-894-8248
Company Executives
- Name
- Position
- Salary
- Kendra Bracken-Ferguson
- Chief Executive Officer
- --
- Bryan J. Cassaday
- Chief Financial Officer and Principal Accounting Officer
- 345.36K
- Rajiv Shukla
- Executive Chairman of the Board
- 1.06M
- Patrick A. Sturgeon
- Independent Director
- 180.39K
- Kathryn Gregory
- Independent Director
- 25.00K
- Dr. Gilles Spenlehauer
- Independent Director
- 167.89K
- Scott Frisch
- Independent Director
- 167.89K
- Richard A. Upton
- Independent Director
- 25.00K
Heat List
US
Overall
Symbol
Price
% Chg
No Data
